Analysts Point To VBI Vaccines Inc. (NASDAQ: VBIV) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Recently, Yahoo Finance discussed the stock, revealing that VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

As a NASDAQ listed company, VBIV falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of VBI Vaccines Inc. is $17.82M. A total of 2.67 million shares were traded on the day, compared to an average of 185.03K shares.

In the most recent transaction, GILLIS STEVEN bought 609,090 shares of VBIV for 1.65 per share on Jul 10 ’23. After the transaction, the Director now owns 1,043,292 company shares. In a previous transaction on Apr 06 ’23, PERCEPTIVE ADVISORS LLC sold 4,251,563 shares at 0.11 per share. VBIV shares that 10% Owner owns now total 41,440,729.

Among the insiders who sold shares, PERCEPTIVE ADVISORS LLC disposed of 1,832,563 shares on Apr 05 ’23 at a per-share price of $0.13. This resulted in the 10% Owner holding 45,691,816 shares of VBIV after the transaction. In another insider transaction, PERCEPTIVE ADVISORS LLC sold 4,810,623 shares at $0.16 per share on Apr 04 ’23. Company shares held by the 10% Owner now total 47,524,379.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, VBIV has a high of $9.54 and a low of $0.45.

As of this writing, VBIV has an earnings estimate of -$0.22 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.22 per share and a lower estimate of -$0.22. The company reported an EPS of -$5.05 in the last quarter, which was -133.80% lower than expectations of -$2.16.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. VBIV’s latest balance sheet shows that the firm has $121.69M in Cash & Short Term Investments as of fiscal 2021. There were $31.80M in debt and $32.59M in liabilities at the time. Its Book Value Per Share was $0.85, while its Total Shareholder’s Equity was $143.88M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VBIV is Buy with a score of 4.50.

Most Popular

Related Posts